Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France
Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Asthma
Phase: N/A
Status: Recruiting
Sponsored by: AstraZeneca Official(s) and/or principal investigator(s):
Stephane SCHÜCK, MD, MSc, Principal Investigator, Affiliation: KAPPA SANTE - Paris - France
Michel AUBIER, MD, Professor, Study Chair, Affiliation: CHU Bichat - Service de pneumologie - Paris - France
Overall contact:
AstraZeneca France Clinical Study Information, Phone: + 33 1 41 29 40 25, Email: florence.thomas@astrazeneca.com
Summary
Descriptive pharmacoepidemiological study on the use of Symbicort Turbuhaler in the
treatment of asthma in France and impact of a new therapeutic strategy on the compliance and
control of asthma
Clinical Details
Official title: Descriptive Pharmacoepidemiological Study on the Use of Symbicort Turbuhaler in the Treatment of Asthma in France and Impact of a New Therapeutic Strategy on the Compliance and Control of Asthma
Study design: Cohort, Prospective
Primary outcome: Level of control of the asthmaEvaluation of compliance with treatment
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Asthmatic patients treated for this disease with Symbicort Turbuhaler
- Patients monitored for asthma by the doctor for at least 12 months
- Patients seen in outpatient care at the baseline visit
- Patients agreeing to participate in the study
Exclusion Criteria:
- Patients with any chronic lower respiratory disease other than asthma
- Patients receiving anti-IgE agents in the last 4 months
- Patients receiving desensitisation treatment outside of the maintenance phase
- Patients deemed to be unable to respond to the study for linguistic or cognitive
reasons
Locations and Contacts
AstraZeneca France Clinical Study Information, Phone: + 33 1 41 29 40 25, Email: florence.thomas@astrazeneca.com
Research Site, Dessenheim, Alsace, France; Recruiting
Research Site, Schiltigheim, Alsace, France; Recruiting
Research Site, Strasbourg, Alsace, France; Recruiting
Research Site, Bordeaux, Aquitainenord, France; Recruiting
Research Site, Bruay La Buissiere, Artois, France; Recruiting
Research Site, St martin Des Champs, Bass Normandie, France; Recruiting
Research Site, Perpignan, Catalogne, France; Recruiting
Research Site, Nice, Esterel, France; Recruiting
Research Site, Vernon, Haute Normandie, France; Recruiting
Research Site, Castelnau Le Lez, Languedoc, France; Recruiting
Research Site, Limoges, Limousin, France; Recruiting
Research Site, Forbach, Lorraine, France; Recruiting
Research Site, Toul, Lorraine, France; Recruiting
Research Site, Lyon, Lyonnais, France; Recruiting
Research Site, Cholet, Pays De Loire, France; Recruiting
Research Site, Nantes, Pays De Loire, France; Recruiting
Research Site, St Quentin, Picardie, France; Recruiting
Research Site, Le Chesnay, Yvelines, France; Recruiting
Additional Information
Starting date: April 2009
Ending date: December 2010
Last updated: May 28, 2009
|
